The store will not work correctly when cookies are disabled.
3,5-Di-(3-hydroxyphenyl)-1H-pyrrolo[2,3-b]pyridine
ID: ALA3102956
PubChem CID: 72792898
Max Phase: Preclinical
Molecular Formula: C19H14N2O2
Molecular Weight: 302.33
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Oc1cccc(-c2cnc3[nH]cc(-c4cccc(O)c4)c3c2)c1
Standard InChI: InChI=1S/C19H14N2O2/c22-15-5-1-3-12(7-15)14-9-17-18(11-21-19(17)20-10-14)13-4-2-6-16(23)8-13/h1-11,22-23H,(H,20,21)
Standard InChI Key: MACHJSMEPKMVPA-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 26 0 0 0 0 0 0 0 0999 V2000
25.1134 -13.4718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.1123 -14.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8269 -14.7117 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.8252 -13.0591 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3990 -13.0596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5404 -13.4681 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.5406 -14.2990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3309 -14.5556 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.8191 -13.8832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.3305 -13.2113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.7184 -12.4841 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5434 -12.4592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9316 -11.7323 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.4953 -11.0312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6669 -11.0617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.2824 -11.7890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4024 -12.2338 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6888 -11.8216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9736 -12.2342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9764 -13.0634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.6906 -13.4718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.2637 -13.4784 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.7559 -11.7050 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 7 2 0
6 4 2 0
4 1 1 0
1 5 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 6 1 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
5 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 5 1 0
20 22 1 0
13 23 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 302.33 | Molecular Weight (Monoisotopic): 302.1055 | AlogP: 4.31 | #Rotatable Bonds: 2 |
Polar Surface Area: 69.14 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.48 | CX Basic pKa: 2.95 | CX LogP: 3.91 | CX LogD: 3.91 |
Aromatic Rings: 4 | Heavy Atoms: 23 | QED Weighted: 0.52 | Np Likeness Score: -0.05 |
References
1. Gourdain S, Dairou J, Denhez C, Bui LC, Rodrigues-Lima F, Janel N, Delabar JM, Cariou K, Dodd RH.. (2013) Development of DANDYs, new 3,5-diaryl-7-azaindoles demonstrating potent DYRK1A kinase inhibitory activity., 56 (23): [PMID:24188002] [10.1021/jm401049v] |